156 related articles for article (PubMed ID: 19164195)
1. Follow-up of intensive glucose control in type 2 diabetes.
Lund SS; Rossing P; Vaag AA
N Engl J Med; 2009 Jan; 360(4):416; author reply 418. PubMed ID: 19164195
[No Abstract] [Full Text] [Related]
2. Follow-up of intensive glucose control in type 2 diabetes.
Mühlhauser I
N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
[No Abstract] [Full Text] [Related]
3. Follow-up of intensive glucose control in type 2 diabetes.
Petrie JR
N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672
[No Abstract] [Full Text] [Related]
4. Glycaemic control in type 2 diabetes.
Campbell A
Clin Evid; 2005 Dec; (14):474-90. PubMed ID: 16620416
[No Abstract] [Full Text] [Related]
5. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
André P
Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
[No Abstract] [Full Text] [Related]
6. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
Bressler R; Johnson DG
Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
[TBL] [Abstract][Full Text] [Related]
7. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
Standl E; Schnell O
Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
[No Abstract] [Full Text] [Related]
8. Diabetes care: what should we try to achieve?
O'Connor PJ
J Fam Pract; 1991 Oct; 33(4):343-4. PubMed ID: 1919448
[No Abstract] [Full Text] [Related]
9. New therapeutic options: management strategies to optimize glycemic control.
Sisam DA
J Am Osteopath Assoc; 2011 Apr; 111(4):300; author reply 300. PubMed ID: 21562302
[No Abstract] [Full Text] [Related]
10. Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapy.
Buse JB
Diabetes Care; 1999 Apr; 22 Suppl 3():C65-70. PubMed ID: 10189565
[No Abstract] [Full Text] [Related]
11. [Combined insulin and sulfonylurea treatment in diabetes mellitus].
Ravina A; Minuhin O
Harefuah; 1986 Jan; 110(1):11-4. PubMed ID: 3514394
[No Abstract] [Full Text] [Related]
12. Insulin initiation in Type 2 diabetes.
Page S
Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
[No Abstract] [Full Text] [Related]
13. Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.
Drzewoski J; Czupryniak L
Med Sci Monit; 2003 Jun; 9(6):CR240-3. PubMed ID: 12824953
[TBL] [Abstract][Full Text] [Related]
14. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the treatment of type II diabetes mellitus.
Baliga BS; Fonseca VA
Am Fam Physician; 1997 Feb; 55(3):817-24. PubMed ID: 9048504
[TBL] [Abstract][Full Text] [Related]
16. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
Goo AK; Carson DS; Bjelajac A
J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
[TBL] [Abstract][Full Text] [Related]
17. Insulin in the early management of diabetic complications.
Miles JM
J Assoc Physicians India; 2003 May; 51():501-5. PubMed ID: 12974435
[TBL] [Abstract][Full Text] [Related]
18. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
[TBL] [Abstract][Full Text] [Related]
19. Insulin regimens in type 2 diabetes.
Cordido F
N Engl J Med; 2010 Mar; 362(10):960; author reply 960. PubMed ID: 20225351
[No Abstract] [Full Text] [Related]
20. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]